The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Regulatory News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 43.20
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Delayed Preliminary Results

23 Mar 2020 16:00

RNS Number : 2589H
Cambridge Cognition Holdings PLC
23 March 2020
 

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

 

Delayed Preliminary Results

 

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces a delay in the publication of its preliminary results following guidance from the Financial Conduct Authority ("FCA").

 

Cambridge Cognition was ready to release its preliminary financial results for the year ended 31 December 2019 on 24 March 2020. However, the FCA has strongly requested that all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks from today's date. Whilst Cambridge Cognition as an AIM quoted company is not formally covered by this request, the Company will be observing this moratorium following advice from its auditors, Grant Thornton. Current guidance is that the Company may need to defer issuing its results for the year ended 31 December 2019 until such time as they are audited.

 

Further information on a revised timetable for publication of the Company's financial statements will be provided in due course.

 

The Company announced a trading update in respect of the year ended 31 December 2019 on 19 February 2020 and the Company anticipates no material differences to the information provided in that announcement.

 

 

Enquiries:

 

Cambridge Cognition Holdings plc

Tel: 01223 810 700

Matthew Stork, Chief Executive Officer

press@camcog.com

Nick Walters, Chief Financial Officer

finnCap Ltd (Nomad and Joint Broker)

Tel: 020 7220 0500

Geoff Nash/ Simon Hicks

(Corporate Finance)

Alice Lane/ Manasa Patil

(Corporate Broking)

Dowgate Capital Limited (Joint Broker)

Tel: 020 3903 7715

David Poutney/ James Serjeant

IFC Advisory Ltd (Financial PR and IR)

Tel: 020 3934 6630

Tim Metcalfe/ Graham Herring/ Zach Cohen

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORBUGDXSSDDGGX
Date   Source Headline
27th Feb 20184:25 pmRNSHolding(s) in Company
10th Jan 20187:00 amRNSTrading Update and Notice of Results
5th Dec 20178:55 amRNSHolding(s) in Company
28th Nov 20177:00 amRNSWearable technology demonstrates high compliance
2nd Nov 20177:00 amRNSGrant of Options
10th Oct 201711:00 amRNSHolding(s) in Company
10th Oct 201710:58 amRNSHolding(s) in Company
6th Oct 20177:00 amRNSIssue of Equity
21st Sep 20177:00 amRNSHalf-year Report
12th Sep 20177:00 amRNSAward of Funding
31st Aug 20177:00 amRNSNotice of Results
12th Jun 20179:56 amRNSHolding(s) in Company
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
7th Jun 20177:00 amRNSSpeech recognition for clinical trials
25th May 20172:22 pmRNSResult of AGM & Board Change
24th May 20174:27 pmRNSHolding(s) in Company
22nd May 20177:00 amRNSIssue of Equity
11th May 20171:07 pmRNSHolding(s) in Company
10th May 20177:00 amRNSGrant of Options
2nd May 20177:00 amRNSPosting of Annual Report & Notice of AGM
30th Mar 20177:00 amRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSAnnual Financial Report
16th Mar 20177:00 amRNSCANTAB used in EBBINGHAUS cognitive function trial
7th Mar 20177:00 amRNSLaunch of web-based testing for virtual research
24th Feb 20177:00 amRNSPartnership With Takeda For Wearables
23rd Feb 20177:00 amRNSNotice of Results
20th Feb 20177:00 amRNSAppointment of Joint Broker
25th Jan 20177:00 amRNSUS regulatory clearance for CANTAB Mobile
4th Nov 20167:00 amRNSGrant of Options
13th Oct 20167:00 amRNSContract
29th Sep 20167:00 amRNSContract Win
22nd Sep 20167:00 amRNSHalf Yearly Report
20th Sep 20167:00 amRNSContract signed
25th Aug 20167:00 amRNSNotice of Results
18th Aug 201610:27 amRNSHolding(s) in Company
16th Aug 20167:00 amRNSCognition Kit Feasibility Study
20th Jul 20167:00 amRNSContract Win
24th Jun 201612:33 pmRNSResult of AGM
22nd Jun 20167:00 amRNSDistribution Agreement with MANUS Neurodynamica
2nd Jun 20167:00 amRNSDistribution Agreement with AnthroTronix
25th May 20162:00 pmRNSNotice of AGM & Posting of Annual Report
6th May 20167:00 amRNSDirector Dealing
5th May 20167:00 amRNSCANTAB Mobile - submission for FDA clearance
3rd May 20163:06 pmRNSHolding(s) in Company
25th Apr 20162:00 pmRNSDirector Dealing
25th Apr 20167:01 amRNSPlacing to raise £1.25m
25th Apr 20167:00 amRNSFinal Results
11th Apr 20167:00 amRNSCANTAB Recruit release
4th Apr 20167:00 amRNSPresentation of Prototype Wearable
30th Mar 20164:06 pmRNSAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.